• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Successful combination chemotherapy for metastatic parathyroid carcinoma.

作者信息

Bukowski R M, Sheeler L, Cunningham J, Esselstyn C

出版信息

Arch Intern Med. 1984 Feb;144(2):399-400.

PMID:6696578
Abstract

A 54-year-old patient with metastatic parathyroid carcinoma and severe hypercalcemia refractory to conventional treatment was treated with chemotherapy consisting of fluorouracil, 500 mg/sq m intravenously (IV) daily for four days (24-hour infusion), cyclophosphamide, 500 mg/sq m IV daily for four days, and dacarbazine (imidazole carboxamide), 200 mg/sq m IV daily for four days. Complete objective and partial biochemical responses were noted, with the response duration being 5.0 + months. The toxic reaction was moderate and predominantly gastrointestinal.

摘要

相似文献

1
Successful combination chemotherapy for metastatic parathyroid carcinoma.
Arch Intern Med. 1984 Feb;144(2):399-400.
2
Parathyroid carcinoma: biochemical and pathologic response to DTIC.甲状旁腺癌:对达卡巴嗪的生化及病理反应
Surgery. 1984 Dec;96(6):1132-7.
3
Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.米托蒽醌、5-氟尿嘧啶和高剂量亚叶酸钙(NFL)与静脉注射环磷酰胺、甲氨蝶呤和5-氟尿嘧啶(CMF)用于转移性乳腺癌患者一线化疗的比较:一项随机II期试验。
Cancer. 1997 Feb 15;79(4):740-8.
4
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.一项针对未经化疗的局部晚期或转移性乳腺癌患者的II期试验,将紫杉醇与24小时输注顺铂联合用于化疗。
Cancer. 2002 Nov 15;95(10):2044-50. doi: 10.1002/cncr.10951.
5
Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.长春瑞滨和顺铂(CIVIC方案)用于含蒽环类和/或紫杉醇方案治疗失败后的转移性乳腺癌治疗。
Cancer. 1998 Jan 1;82(1):134-40.
6
Treatment of patients with upper gastrointestinal carcinomas.上消化道癌患者的治疗
Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-72-S19-76.
7
Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study.口服雌莫司汀与环磷酰胺治疗转移性激素难治性前列腺癌患者:一项II期研究。
Cancer. 2000 Mar 15;88(6):1438-44.
8
[5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer].5-氟尿嘧啶和顺铂联合化疗用于转移性肛管鳞状细胞癌
Bull Cancer. 1999 Oct;86(10):861-5.
9
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.欧洲癌症研究与治疗组织(EORTC)08957 号研究:拓扑替康联合顺铂作为难治性和敏感性小细胞肺癌二线治疗的 II 期研究
Clin Cancer Res. 2003 Jan;9(1):143-50.
10
[Treatment of metastatic adrenal carcinoma with suramin].用苏拉明治疗转移性肾上腺癌
Dtsch Med Wochenschr. 1989 Mar 10;114(10):381-4. doi: 10.1055/s-2008-1066605.

引用本文的文献

1
Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature.帕博利珠单抗联合外放射治疗有效控制 TMB 高不可切除复发性甲状旁腺癌:病例报告并文献复习。
Endocr J. 2024 Nov 1;71(11):1069-1075. doi: 10.1507/endocrj.EJ24-0126. Epub 2024 Jul 10.
2
Parathyroid Carcinoma Presenting as Recurrent Primary Hyperparathyroidism and Neck Mass: A Case Report.表现为复发性原发性甲状旁腺功能亢进和颈部肿块的甲状旁腺癌:一例报告
touchREV Endocrinol. 2023 Jul;19(2):80-85. doi: 10.17925/EE.2023.19.2.6. Epub 2023 Jul 11.
3
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases.
转移性甲状旁腺癌的治疗与转归:已发表病例的系统评价与汇总分析
Front Oncol. 2022 Sep 26;12:997009. doi: 10.3389/fonc.2022.997009. eCollection 2022.
4
Parathyroid Carcinoma: a Review.甲状旁腺癌:综述
Indian J Surg Oncol. 2022 Mar;13(1):133-142. doi: 10.1007/s13193-021-01343-3. Epub 2021 Jun 3.
5
Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives.甲状旁腺癌:发病率、生存分析与管理:来自监测、流行病学和最终结果(SEER)数据库的研究及对未来治疗前景的见解
Cancers (Basel). 2022 Mar 10;14(6):1426. doi: 10.3390/cancers14061426.
6
Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report.地舒单抗治疗甲状旁腺癌高钙血症 1 例报告
Front Endocrinol (Lausanne). 2022 Jan 31;12:794988. doi: 10.3389/fendo.2021.794988. eCollection 2021.
7
Metastatic parathyroid cancer: a rare cause of hypercalcaemia.转移性甲状旁腺癌:高钙血症的罕见病因。
BMJ Case Rep. 2021 Oct 28;14(10):e244302. doi: 10.1136/bcr-2021-244302.
8
[The clinical practice guidelines for primary hyperparathyroidism, short version].[原发性甲状旁腺功能亢进症临床实践指南,简版]
Probl Endokrinol (Mosk). 2021 Aug 19;67(4):94-124. doi: 10.14341/probl12801.
9
Synchronous intrathyroidal parathyroid carcinoma and thyroid carcinoma: case report and review of the literature.甲状腺内甲状旁腺癌和甲状腺癌同步发生:病例报告及文献复习。
BMC Endocr Disord. 2021 Apr 7;21(1):60. doi: 10.1186/s12902-021-00724-7.
10
Current concepts in parathyroid carcinoma: a single Centre experience.甲状旁腺癌的现代概念:单中心经验。
BMC Endocr Disord. 2019 May 29;19(Suppl 1):46. doi: 10.1186/s12902-019-0368-1.